Softigel by Procaps will be attending CPhi Worldwide in Madrid. Our team of experts will be delighted to sit with you and discuss mutual opportunities.
To schedule a meeting click here
Softigel by Procaps Develops manufactures and commercializes pharmaceutical, nutritional, veterinary and cosmetics products worldwide. We are Latin America's largest softgel encapsulator, with an annual capacity of 11 billion doses, plus our more than 500 softgel formulations experience, and facilities recently approved by FDA, MHRA and TGA.
Softigel is part of the Procaps Group, a diversified brand in charge of Healthcare and related businesses, including soft-gel capsule manufacturing, advanced new drug delivery technologies, and a Pharmaceutical Division with a network distribution that reaches 48 countries around the world.
At CPhI, Softigel seeks new OTC consumer healthcare, generic Rx and pharma customers with collaboration opportunities inside the US, other highly regulated markets or elsewhere worldwide, we suited to traditional softgel or our advanced drug delivery technologies such as UnigelTM
(the only patented technology for fixed dose combinations), VersagelsTM
(a new approach to vegetarian soft capsules), GummygelsTM
(pharma gummies); and many more.